Research and Markets: Global Osteoporosis Drugs Market 2014-2018: One of the Main Challenges is the Multiple Patent Expirations
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jhq3x3/global) has announced the addition of the "Global Osteoporosis Drugs Market 2014-2018" report to their offering.
The analysts forecast the Global Osteoporosis Drugs market to grow at a CAGR of 3.98 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing global aging population. The Global Osteoporosis Drugs market has also been witnessing the increasing awareness of bone health education. However, the multiple patent expiries could pose a challenge to the growth of this market.
Key vendors dominating this space are Amgen Inc., Eli Lilly & Co., Merck & Co. Inc., and Novartis AG.
Other vendors mentioned in the report are Abiogen Pharma SpA, F. Hoffmann La Roche Ltd., GlaxoSmithKline plc, Ligand Pharmaceuticals Inc., NPS Pharma Inc., and Pfizer Inc.
Commenting on the report, an analyst from the team said: There has been an increase in awareness of bone education among patients and physicians. Enhanced patient and physician awareness is expected to lead to earlier disease diagnosis and treatment. The acceptability of osteoporosis drugs is expected to rise due to the increasing public awareness. This will probably result in increasing drug penetration. Raising general awareness about osteoporosis has led to an increase in research funding and support for clinical and support services. For instance, May is celebrated as National Osteoporosis Awareness and Prevention Month every year.
This has encouraged women and men to start conversations about bone health and family history as the first steps to protecting themselves and future generations from osteoporosis. Similarly, the National Osteoporosis Foundation is the leading health organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life, and reducing human suffering, through programs of public and clinician awareness, education, advocacy, and research. These collaborations have helped to considerably increase the awareness about osteoporosis drugs.
For more information visit http://www.researchandmarkets.com/research/jhq3x3/global
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.